Skip to content

Using Personalized Assessments in the Treatment of Childhood OCD

Using Personalized Assessments in the Treatment of Childhood OCD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06407648
Enrollment
30
Registered
2024-05-09
Start date
2024-04-03
Completion date
2026-12-30
Last updated
2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive-Compulsive Disorder

Keywords

children, adolescents, exposure with response prevention, cognitive behavioral therapy, ERP, CBT

Brief summary

The primary purpose of this study is to learn whether personalized assessment of obsessive-compulsive disorder (OCD) symptoms in childhood OCD using mobile health technology are feasible and acceptable for youth and parents. The investigators will also examine whether personalized cognitive-behavioral therapy (CBT) that is informed by personalized OCD assessments yields better clinical outcomes when compared to standard CBT for youth with OCD

Interventions

OTHERPersonalized Assessments

Personalized CBT will use individualized OCD symptom networks to guide CBT strategies to target central symptom nodes in contemporaneous networks.

OTHERStandard of Care

The standard CBT condition will use standard-of-care approaches to guide CBT strategies to target OCD symptoms.

Sponsors

Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Randomized parallel clinical trial

Eligibility

Sex/Gender
ALL
Age
8 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

1. be 8-17 years of age; 2. meet diagnostic criteria for a primary diagnosis of OCD on a structured clinical interview; 3. have moderate OCD severity as evidenced by a CY-BOCS total score of ≥16; 4. medication free and/or on a stable dose of medication 8 weeks prior to study participation; 5. be English speaking.

Exclusion criteria

1. the presence of psychotic disorder, bipolar disorder, or autism spectrum disorders; 2. significant suicidal ideation that warrants medical intervention; 3. concurrent psychotherapy for OCD; 4. inability to complete scales, or attend visits.

Design outcomes

Primary

MeasureTime frameDescription
Children's Yale-Brown Obsessive-Compulsive Scale Second Edition (CY-BOCS-II) Total Severity ScoreScreen, Baseline (Week 0), Week 4, Week 8, and Week 12A clinician-rated measure of OCD symptom severity in the past week. This 10-item measure is rated on a 0 to 5 scale with a total score ranging from 0 to 50. A higher total score is reflective of greater OCD symptom severity.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORJoseph F. McGuire, PhD

Johns Hopkins University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026